Robert Tipp, Chief Investment Strategist at PGIM Fixed Income, on potential Fed rate cuts and current investment outlook. Dr. Phil Chan, CEO of CytoSorbents (NASDAQ: CTSO), discusses the medical issues surrounding the coronavirus threat, and their technology that can treat compromised immune systems. Michael Tiedemann, CEO of Tiedemann Advisors, on how they’re advising clients in the sell-off. Brian Chappatta on his column: "Bond Traders See Fed Facing All-or-Nothing Call." Hosted by Lisa Abramowicz and Paul Sweeney.
See omnystudio.com/listener for privacy information.
